Username not available
| FCS Software
| Hind Constr
| Jaiprakash Asso
| Jindal PolyFilm
| Praj Industries
| Reliance Comm
| Suzlon Energy
| TCI Finance
| Tata Motors
| Tata Steel
Other Market Topics
yes in the short medium and long runs
Get started using your favorite social network
Login using moneycontrol ID
Need help logging in? Reset password.
Simply sign up using this short form
Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter
S&P BSE Sensex
Sector : Pharmaceuticals
Jun 28, 11:43
Cadila Healthcare gains 1% on USFDA approval for Oxybutynin tablets
Jun 28, 10:26
Cadila Healthcare gets US FDA approval for Oxybutynin Chloride Extended-Release Tablets
Jun 27, 12:15
Cadila Healthcare rises 2% on fund raising plan, USFDA approval
Jun 27, 10:27
Zydus receives final approval from USFDA for Entecavir tablets
Jun 28, 00:00
Jun 27, 00:00
Jun 28, 10:24
Jun 28, 14:33
Pharma many and PSU banks may deliver 100-150 percent returns in coming 12-15 months ... see more
Bro..let me reiterate over here..as I said every time..that it was only your guidance by which I trimmed my losses especially in Canara Bank, Maruti and booked profits in Divis Labs. I am always greatful to you..for sharing trading ideas wi...  see more
write to Forum Messenger
Cadila Healthcare gets US FDA approval for Oxybutynin Chloride Extended-Release Tablets. Have an opinion on this news? Post your comment here.
Confused? use our Compare Brokers feature.
Thank you for registering.
Respective broker representative will reach you shortly.
Choose your nickname
Use your userid as your nickname
Your permanent Nickname can be distinct from your username and no one need know the link between the two.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form
or medium without express writtern permission of moneycontrol.com is prohibited.